Precise Identification of a Human Immunodeficiency Virus Type 1 Antigen Processing Mutant

ABSTRACT Human immunodeficiency virus type 1 (HIV-1) evokes a strong immune response, but the virus persists. Polymorphisms within known antigenic sites result in loss of immune recognition and can be positively selected. Amino acid variation outside known HLA class I restricted epitopes can also enable immune escape by interfering with the processing of the optimal peptide antigen. However, the lack of precise rules dictating epitope generation and the enormous genetic diversity of HIV make prediction of processing mutants very difficult. Polymorphism E169D in HIV-1 reverse transcriptase (RT) is significantly associated with HLA-B*0702 in HIV-1-infected individuals. This polymorphism does not map within a known HLA-B*0702 epitope; instead, it is located five residues downstream of a HLA-B*0702-restricted epitope SPAIFQSSM (SM9). Here we investigate the association between E169D and HLA-B*0702 for immune escape via the SM9 epitope. We show that this single amino acid variation prevents the immune recognition of the flanked SM9 epitope by cytotoxic T cells through lack of generation of the epitope, which is a result of aberrant proteasomal cleavage. The E169D polymorphism also maps within and abrogates the recognition of an HLA-A*03-restricted RT epitope MR9. This study highlights the potential for using known statistical associations as indicators for viral escape but also the complexity involved in interpreting the immunological consequences of amino acid changes in HIV sequences.

[1]  Edward C. Holmes,et al.  Sexual Transmission of Single Human Immunodeficiency Virus Type 1 Virions Encoding Highly Polymorphic Multisite Cytotoxic T-Lymphocyte Escape Variants , 2005, Journal of Virology.

[2]  P. Easterbrook,et al.  CD8+ T Cell Epitope-Flanking Mutations Disrupt Proteasomal Processing of HIV-1 Nef1 , 2005, The Journal of Immunology.

[3]  D. Cooper,et al.  A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1. , 2005, AIDS research and human retroviruses.

[4]  Bette Korber,et al.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.

[5]  D. Cooper,et al.  Frequent Transmission of Cytotoxic-T-Lymphocyte Escape Mutants of Human Immunodeficiency Virus Type 1 in the Highly HLA-A24-Positive Japanese Population , 2004, Journal of Virology.

[6]  B. Walker,et al.  Immune Escape Precedes Breakthrough Human Immunodeficiency Virus Type 1 Viremia and Broadening of the Cytotoxic T-Lymphocyte Response in an HLA-B27-Positive Long-Term-Nonprogressing Child , 2004, Journal of Virology.

[7]  Philip J. R. Goulder,et al.  HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.

[8]  W. Heneine,et al.  Transmitted Human Immunodeficiency Virus Type 1 Carrying the D67N or K219Q/E Mutation Evolves Rapidly to Zidovudine Resistance In Vitro and Shows a High Replicative Fitness in the Presence of Zidovudine , 2004, Journal of Virology.

[9]  P. Kloetzel,et al.  Hepatitis C virus mutation affects proteasomal epitope processing. , 2004, The Journal of clinical investigation.

[10]  Alessandro Sette,et al.  Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[11]  M. Altfeld,et al.  Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection , 2004, The Journal of experimental medicine.

[12]  J. Benito,et al.  The role of CD8+ T-cell response in HIV infection. , 2004, AIDS reviews.

[13]  Austin L. Hughes,et al.  Extraepitopic Compensatory Substitutions Partially Restore Fitness to Simian Immunodeficiency Virus Variants That Escape from an Immunodominant Cytotoxic-T-Lymphocyte Response , 2004, Journal of Virology.

[14]  Yoshiyuki Nagai,et al.  Impaired Processing and Presentation of Cytotoxic-T-Lymphocyte (CTL) Epitopes Are Major Escape Mechanisms from CTL Immune Pressure in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.

[15]  Steven Wolinsky,et al.  Simian-Human Immunodeficiency Virus Escape from Cytotoxic T-Lymphocyte Recognition at a Structurally Constrained Epitope , 2003, Journal of Virology.

[16]  D. Tough,et al.  IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells , 2003, The Journal of Immunology.

[17]  D. Tough,et al.  IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells1 , 2003, The Journal of Immunology.

[18]  Concepción Marañón,et al.  An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope , 2003, Nature Immunology.

[19]  Els Goulmy,et al.  Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides. , 2003, Human immunology.

[20]  J. Altman,et al.  IL-15 enhances survival and function of HIV-specific CD8+ T cells. , 2003, Blood.

[21]  M. Bunce.  PCR-sequence-specific primer typing of HLA class I and class II alleles. , 2003, Methods in molecular biology.

[22]  H. Günthard,et al.  Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load , 2002, AIDS.

[23]  Hong Yu,et al.  Mutational Analysis of HIV-1 Long Terminal Repeats to Explore the Relative Contribution of Reverse Transcriptase and RNA Polymerase II to Viral Mutagenesis* , 2002, The Journal of Biological Chemistry.

[24]  H. Günthard,et al.  Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Søren Brunak,et al.  Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation , 2002, Journal of Virology.

[26]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[27]  B. Walker,et al.  Immunologic control of HIV-1. , 2002, Annual review of medicine.

[28]  P. Klenerman,et al.  HIV/AIDS. HLA leaves its footprints on HIV. , 2002, Science.

[29]  Bette T. Korber,et al.  Immune control of HIV: the obstacles of HLA and viral diversity , 2001, Nature Immunology.

[30]  S. Rowland-Jones,et al.  Cellular immune responses to HIV , 2001, Nature.

[31]  Edward C. Holmes,et al.  Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.

[32]  P M Kloetzel,et al.  Abrogation of CTL Epitope Processing by Single Amino Acid Substitution Flanking the C-Terminal Proteasome Cleavage Site1 , 2000, The Journal of Immunology.

[33]  R. Hohlfeld,et al.  T cell transformation with Herpesvirus saimiri: a tool for neuroimmunological research , 2000, Journal of Neuroimmunology.

[34]  Z. Grubic,et al.  Polymorphism of HLA-A, -B, -DRB1, -DQA1 and -DQB1 haplotypes in a Croatian population. , 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[35]  J. Trowsdale,et al.  IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. , 1999, Journal of immunology.

[36]  P. Klenerman,et al.  The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infection , 1998, Journal of Molecular Medicine.

[37]  A. Hill,et al.  Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. , 1997, Journal of immunological methods.

[38]  A. McMichael,et al.  Rapid Effector Function in CD8+ Memory T Cells , 1997, The Journal of experimental medicine.

[39]  P. Klenerman,et al.  Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  L. Eisenlohr,et al.  Regulation of class I-restricted epitope processing by local or distal flanking sequence. , 1997, Journal of immunology.

[41]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[42]  D. Stuart,et al.  Antagonist HIV-1 Gag Peptides Induce Structural Changes in HLA B8 , 1996, The Journal of experimental medicine.

[43]  C. Boucher,et al.  Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay , 1996, Antimicrobial agents and chemotherapy.

[44]  P M Kloetzel,et al.  A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. , 1996, Immunity.

[45]  P. Klenerman,et al.  Cytotoxic T Lymphocyte Lysis Inhibited by Viable HIV Mutants , 1995, Science.

[46]  P. Klenerman,et al.  Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. , 1995, Journal of immunology.

[47]  D. Soll,et al.  HIV-induced syncytia of a T cell line form single giant pseudopods and are motile. , 1993, Journal of cell science.

[48]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.

[49]  E. Lennette,et al.  Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections , 1989 .

[50]  Huisman,et al.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex , 1988, Journal of virology.

[51]  L. Powell,et al.  Idiopathic haemochromatosis in the Australian population: HLA linkage and recessivity. , 1981, Human immunology.